In 2018, the entrepreneurs of Biodeconta discovered the opportunities in the domestic glove integrity testing market. At that time, the domestic glove integrity testing equipment was bulky with limited performance. Compared with similar European products, there was a significant gap in terms of volume, stability, testing speed, testing accuracy and other indicators. Seizing this opportunity, the founders of Biodeconta were eager to develop a set of glove integrity testing instruments with an internationally leading level, aiming to improve the domestic testing level of glove integrity testing instruments and strive to become an industry benchmark. Based on this aspiration, the founders of Biodeconta dedicated themselves to providing professional products and services to the domestic pharmaceutical industry.

In March 2019, in the vibrant spring, Biodeconta was founded as anticipated. At the start, the R & D team, lacking product development experience, faced many challenges during development. Yet, undaunted, they pooled resources and, within just 3 months, developed the first prototype, achieving the initial product concept.
As the project advanced, they realized the prototype fell short of high - quality and high - performance standards. Challenges like hardware development, software upgrades, hardware - software integration, and defining customer needs piled up. But the team persevered, making steady R & D efforts, driven by the goal of becoming an industry benchmark.

From 2019 to 2021, during the days when the pandemic spread and fluctuated, the company's R & D team grew in adversity, experiencing a transformative journey from scratch to a state of maturity. During this period, Biodeconta endured numerous failures. However, failure did not defeat Biodeconta, as it understood that failure is an inevitable step on the path to success. Thus, undeterred, through multiple adjustments and reorganizations, Biodeconta finally established a mature R & D framework by the end of 2021 and advanced the development of the glove integrity tester to its final stage.
At the same time, Biodeconta identified its future development direction. Rooted in the biological purification industry, it aims to become a leading provider of services and high - quality equipment in this field. Consequently, the R & D team officially shifted its focus to the development of space microbial purification equipment.

2022 was an especially challenging year, with the industry rife with changes and hurdles. However, Biodeconta was determined to persevere on the path of optimized and innovative development. As the saying goes, "A long journey reveals a horse's strength; time discloses a person's heart." Diligent and pragmatic, Biodeconta made remarkable progress in this year.
After years of optimization and improvement, the glove integrity testing equipment evolved into two product lines, the 50 series and the 100 series. In terms of both appearance design and product performance, it exceeded the initial product concept when the company was founded and reached a top - notch domestic level. Meanwhile, the glove integrity equipment gradually won customer recognition and entered the mass - production and continuous - optimization stage.The biological purification service and R & D team also achieved breakthrough progress.

Since there are numerous factors affecting space biological purification, and the purification results depend not only on the quality of the equipment but also on the skill level of the operators. Biodeconta anticipates and addresses the concerns of its customers. At the very beginning of launching its biological purification business, it recognized the necessity of on - site biological purification services. Therefore, it established this service as a strategic business unit of the company, dedicated to providing a high - quality service experience and high - standard quality delivery.
By the end of 2023, the self - developed biological purification equipment of Biodeconta had provided customers with high - quality biological purification services for nearly two years. Whether day or night, through the changing seasons, in severe cold, intense heat, wind, frost, rain or snow, our equipment can operate normally and safely achieve the Log6 purification target. This has broken through the usage bottleneck of similar equipment in the industry, winning the trust and respect of customers, as well as achievements and affirmation. It has enabled Biodeconta to take a solid step towards its set goals.

In 2024, Biodeconta started validating and producing glove integrity testing equipment. We sent our products to SGS for CE and FCC testing. Based on the test results, we optimized the products. Uniquely in the industry, we offer a 5 - year product quality guarantee.
Our glove integrity testing equipment has been updated repeatedly. In terms of hardware, the latest version weighs less than 2.0KG. For software, we've improved the user - interface and functionality.
At Biodeconta, service and responsibility are at the core. By addressing customers' concerns and ensuring their satisfaction, we aim to become an industry benchmark.

Looking ahead, Biodeconta is brimming with anticipation. We're eager and ready to go, aspiring to continuously deliver even higher - quality products and services to our customers through our unwavering pursuit of top - notch product quality and excellent service. We firmly believe that with continuous improvement and innovation, as well as ceaseless efforts and progress, Biodeconta is bound to become a leader in providing solutions for biological purification service systems. We look forward to walking hand in hand with our customers and striding towards a successful future.